ATAGI recommendations

Use of Bexsero vaccine as a booster dose in individuals at standard background risk of invasive meningococcal disease

Use of Bexsero vaccine as a booster dose in individuals at increased risk of invasive meningococcal disease

Use of Trumenba vaccine as a booster dose in individuals at standard background risk of invasive meningococcal disease

Use of Trumenba vaccine as a booster dose in individuals at increased risk of invasive meningococcal disease

 

Meningococcal B booster vaccines (Bexsero and Trumenba)

Coversheet on evidence assessment by ATAGI using the GRADE framework for meningococcal B booster vaccine

 

Bexsero

Compared to no booster for individuals at standard background risk of invasive meningococcal disease (IMD)

Compared to no booster for individuals at increased risk of invasive meningococcal disease (IMD)

 

Trumenba

Compared to no booster vaccine for individuals at standard background risk of invasive meningococcal disease (IMD)

Compared to no booster vaccine for individuals at increased risk of invasive meningococcal disease (IMD)

 

Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.

View the meningococcal disease chapter in the Handbook here

Last updated February 2024